190 related articles for article (PubMed ID: 19695142)
1. Economic impact of a rotavirus vaccination program in Mexico.
Constenla D; Velázquez FR; Rheingans RD; Antil L; Cervantes Y
Rev Panam Salud Publica; 2009 Jun; 25(6):481-90. PubMed ID: 19695142
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
5. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China.
Liu N; Yen C; Fang ZY; Tate JE; Jiang B; Parashar UD; Zeng G; Duan ZJ
Vaccine; 2012 Nov; 30(48):6940-5. PubMed ID: 22705174
[TBL] [Abstract][Full Text] [Related]
6. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries.
Rheingans RD; Constenla D; Antil L; Innis BL; Breuer T
Rev Panam Salud Publica; 2007 Apr; 21(4):205-16. PubMed ID: 17612464
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of a rotavirus vaccine in Brazil.
Constenla DO; Linhares AC; Rheingans RD; Antil LR; Waldman EA; da Silva LJ
J Health Popul Nutr; 2008 Dec; 26(4):388-96. PubMed ID: 19069617
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.
Valencia-Mendoza A; Bertozzi SM; Gutierrez JP; Itzler R
BMC Infect Dis; 2008 Jul; 8():103. PubMed ID: 18664280
[TBL] [Abstract][Full Text] [Related]
10. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
11. [Potential cost effectiveness of a rotavirus vaccine in Chile].
Constenla D; O'Ryan M; Navarrete MS; Antil L; Rheingans RD
Rev Med Chil; 2006 Jun; 134(6):679-88. PubMed ID: 17130941
[TBL] [Abstract][Full Text] [Related]
12. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.
Pecenka C; Parashar U; Tate JE; Khan JAM; Groman D; Chacko S; Shamsuzzaman M; Clark A; Atherly D
Vaccine; 2017 Jul; 35(32):3982-3987. PubMed ID: 28623028
[TBL] [Abstract][Full Text] [Related]
13. [Economic impact of rotavirus vaccination in Panama].
Constenla D; Ortega-Barría E; Rheingans RD; Antil L; Sáez-Llorens X
An Pediatr (Barc); 2008 Feb; 68(2):128-35. PubMed ID: 18341878
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of rotavirus vaccination in Albania.
Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
16. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule.
Milne RJ; Grimwood K
Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of the economic impact of the antiretroviral vaccine in Venezuela].
Constenla D; Pérez-Schael I; Rheingans RD; Antil L; Salas H; Yarzábal JP
Rev Panam Salud Publica; 2006 Oct; 20(4):213-22. PubMed ID: 17316479
[TBL] [Abstract][Full Text] [Related]
18. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
Wu CL; Yang YC; Huang LM; Chen KT
Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]